Skip to main content

Herbert Timothy P.'s Form 4 filing

Inspire Medical Systems, Inc.INSP · filed Sep 13, 2023

Accession no.
0001104659-23-100460
Filed
Sep 13, 2023
Trade date
Sep 8, 2023
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 10 derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Herbert Timothy P.CIK 0001737136Director, Officer (CEO and President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 8, 2023Common StockGGiftDisposed−47,992$0.00$0106,651Indirect
Sep 8, 2023Common StockSSaleDisposed−47,992–F4–106,651Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 8, 2023Common StockGGiftDisposed−9,793$0.00$021,762Indirect
Sep 8, 2023Common StockGGiftDisposed−23,361$0.00$051,913Indirect
Sep 8, 2023Common StockGGiftDisposed−24,720$0.00$054,934Indirect
Sep 8, 2023Common StockGGiftDisposed−11,745$0.00$026,100Indirect
Sep 8, 2023Common StockGGiftDisposed−2,499$0.00$05,553Indirect
Sep 8, 2023Common StockSSaleDisposed−9,793–F4–21,762Indirect
Sep 8, 2023Common StockSSaleDisposed−23,361–F4–51,913Indirect
Sep 8, 2023Common StockSSaleDisposed−24,720–F4–54,934Indirect
Sep 8, 2023Common StockSSaleDisposed−11,745–F4–26,100Indirect
Sep 8, 2023Common StockSSaleDisposed−2,499–F4–5,553Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

The sale price of the transaction described in footnote (3) will be subsequently determined by a third-party valuation firm.

Referenced by the price of 1 transaction in Table I and 5 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)